TH1701003125A - Etherphospholipids and methods for the production of this substance. - Google Patents
Etherphospholipids and methods for the production of this substance.Info
- Publication number
- TH1701003125A TH1701003125A TH1701003125A TH1701003125A TH1701003125A TH 1701003125 A TH1701003125 A TH 1701003125A TH 1701003125 A TH1701003125 A TH 1701003125A TH 1701003125 A TH1701003125 A TH 1701003125A TH 1701003125 A TH1701003125 A TH 1701003125A
- Authority
- TH
- Thailand
- Prior art keywords
- disease
- ether
- phospholipids
- etherphospholipids
- methods
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract 3
- 239000000126 substance Substances 0.000 title 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract 8
- 229940067631 Phospholipids Drugs 0.000 claims abstract 6
- -1 ether phospholipids Chemical class 0.000 claims abstract 4
- 210000001519 tissues Anatomy 0.000 claims abstract 4
- 206010001897 Alzheimer's disease Diseases 0.000 claims abstract 2
- 241000193882 Corbicula Species 0.000 claims abstract 2
- 210000003792 Cranial Nerves Anatomy 0.000 claims abstract 2
- 206010012601 Diabetes mellitus Diseases 0.000 claims abstract 2
- 241000287828 Gallus gallus Species 0.000 claims abstract 2
- 206010021425 Immune system disease Diseases 0.000 claims abstract 2
- 208000008589 Obesity Diseases 0.000 claims abstract 2
- 206010061536 Parkinson's disease Diseases 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims abstract 2
- 201000009910 diseases by infectious agent Diseases 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims abstract 2
- 238000000605 extraction Methods 0.000 claims abstract 2
- 235000020824 obesity Nutrition 0.000 claims abstract 2
- 150000003904 phospholipids Chemical class 0.000 claims abstract 2
- 201000000980 schizophrenia Diseases 0.000 claims abstract 2
- 235000015170 shellfish Nutrition 0.000 claims abstract 2
Abstract
แก้ไขใหม่ 4/9/2560 [ปัญหาที่แก้ไข] อีเทอร์ฟอสโฟลิพิดมีความสามารถที่เหนือกว่าแบบดั้งเดิมและวิธีการสำหรับการผลิต ในวิธีที่ง่ายเหมือนกันในขอบเขตทางอุตสาหกรรม ในแง่ของผลของการรักษาและการปรับปรุงโรค เส้นประสาทในกะโหลกศีรษะเช่นโรคอัลไซเมอร์ โรคพาร์กินสัน โรคซึมเศร้าและโรคจิตเภท โรคอ้วนลง พุง เช่นเบาหวาน โรคติดเชื้อต่างๆ และโรคภูมิคุ้มกัน [การแก้ปัญหา] อีเทอร์ฟอสโฟลิพิดที่ได้รับจากเนื้อเยื่อไบวาล์วเช่นหอยและคอร์ไบคิวลาโดย กระบวนการสกัด อีเทอร์ฟอสโฟลิพิดแสดงผลดีกว่าอย่างมีนัยสำคัญของข้างบนเปรียบเทียบกับอีเทอร์ ฟอสโฟลิพิดแบบดั้งเดิมที่ได้มาจากเนื้อเยื่อจากไก่ New Correction 4/9/2017 [Resolved Issues] ether phospholipids have superior capabilities and methods for manufacturing. In the same easy way in the industrial scope In terms of effects of treatment and disease improvement Cranial nerves such as Alzheimer's disease Parkinson's disease Depression and schizophrenia, obesity, such as diabetes, various infectious diseases And immune disease [Solution] ether phospholipids obtained from bi-valve tissues such as shellfish and corbicula by Extraction process Etherphospholipids show significantly better results than those of the above compared to ether. Traditional phospholipids are obtained from chicken tissue.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH1701003125A true TH1701003125A (en) | 2019-09-16 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2017030823A3 (en) | Anti-tigit antibodies | |
| MX2019012081A (en) | Human fibroblast growth factor 21 (hfgf21) fusion protein, preparation method therefor, and use thereof. | |
| EA201590251A1 (en) | NEW 5-AMINOTETRAHYDROHINOLIN-2-CARBONIC ACIDS AND THEIR APPLICATION | |
| BR112017020824A2 (en) | derived from imidazo-isoindole, method of preparation of it and medical use of it | |
| SA515360007B1 (en) | Heteroaromatic compounds as bruton's tyrosine kinase (BTK) inhibitors | |
| EA201791535A1 (en) | NEW CONNECTION 4'-TIONOUCLEOSIDE, AND ALSO THE WAY OF ITS OBTAINING, ITS PHARMACEUTICAL COMPOSITION AND APPLICATION | |
| EA201690520A1 (en) | METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES | |
| MX2015012435A (en) | Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders. | |
| BR112017023740A2 (en) | "solid form of a compound, process for preparing a solid form, pharmaceutical composition, method for treating or preventing disease and using a solid form"; | |
| BR112018006866A2 (en) | ppar agonist compounds, pharmaceutical compositions and methods of use thereof | |
| PH12016500814A1 (en) | Heteroaryl butanoic acid derivatives | |
| EA201890449A1 (en) | FUMAGILLINUM HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND APPLICATION | |
| EA201501175A1 (en) | NEW CONNECTIONS FOR THE TREATMENT OF MALIGNANT NOW-FORMATION | |
| PH12018500992A1 (en) | Nutritional compositions comprising a casein hydrolysate, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate | |
| WO2017103094A3 (en) | Means and methods for treating copper-related diseases | |
| RU2019110980A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A 15-HEPC AND METHODS FOR TREATING ASTHMA AND LUNG DISEASES WITH THEIR APPLICATION | |
| MX2018000462A (en) | Methods of chemical synthesis of substituted 10h-phenothiazine-3, 7-diamine compounds. | |
| WO2017029558A3 (en) | Methods for improving health of farmed fish | |
| EA201591704A1 (en) | NEW SUSTAINABLE SALTS OF PENTADECEPEPTIDE, METHOD OF THEIR PRODUCTION, THEIR APPLICATION IN THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION IN THERAPY | |
| WO2014141169A3 (en) | Novel anti-neurodegenerative natural compounds isolated from alpiniae oxyphyllae fructus and total synthesis theirof | |
| TH1701003125A (en) | Etherphospholipids and methods for the production of this substance. | |
| SG11201811499WA (en) | Crystal forms of a 9-aminomethyl substituted tetracycline compound and a preparation method thereof | |
| CN107406419A8 (en) | PET developers | |
| BR112017006177A2 (en) | immunostimulatory compounds | |
| CL2014001823A1 (en) | Stereoselective preparation process of a compound derived from 9-hydroxy-5-oxo-1,4-diaza-spiro [5.5] undecano; intermediary compounds; use in the treatment of tumor diseases, diseases of the lung and respiratory tract. |